Literature DB >> 20105643

Parenteral fish oil-associated burr cell anemia.

Husam S Mallah1, Marilyn R Brown, Thomas M Rossi, Robert C Block.   

Abstract

We report the development of burr cell anemia in an infant with short bowel syndrome who received parenteral fish oil (Omegaven, Fresenius-Kabi, Graz, Austria) after development of total parenteral nutrition-associated liver disease. Parenteral fish oil was discontinued, and the burr cell anemia disappeared, suggesting that parenteral fish oil might be associated with hemolytic anemia. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20105643      PMCID： PMC3365505          DOI： 10.1016/j.jpeds.2009.07.062

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  10 in total

1.  Influence of a parenteral fish-oil preparation (Omegaven) on erythrocyte morphology and blood viscosity in vitro.

Authors:  L Fischler; D O Meredith; W H Reinhart
Journal:  Clin Hemorheol Microcirc       Date:  2003       Impact factor: 2.375

2.  Echinocytosis--an unusual manifestation of hemangioma.

Authors:  Ivy Altomare; Garrett Desman; Louis M Aledort
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

3.  Influence of parenteral fat emulsion Intralipos and citric acid on blood viscosity and erythrocyte morphology in vitro.

Authors:  Yiyao Liu; Hong Yang; Quansheng Su; Akio Sakanishi
Journal:  Colloids Surf B Biointerfaces       Date:  2006-08-07       Impact factor: 5.268

4.  Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.

Authors:  Kathleen M Gura; Christopher P Duggan; Sharon B Collier; Russell W Jennings; Judah Folkman; Bruce R Bistrian; Mark Puder
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

5.  Present status of spiculed red cells and their relationship to the discocyte-echinocyte transformation: a critical review.

Authors:  G Brecher; M Bessis
Journal:  Blood       Date:  1972-09       Impact factor: 22.113

6.  Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.

Authors:  Ivan R Diamond; Anca Sterescu; Paul B Pencharz; Jae H Kim; Paul W Wales
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

7.  Effect of dietary (n-9), (n-6) and (n-3) fatty acids on membrane lipid composition and morphology of rat erythrocytes.

Authors:  A Escudero; J C Montilla; J M García; M C Sánchez-Quevedo; J L Periago; P Hortelano; M D Suárez
Journal:  Biochim Biophys Acta       Date:  1998-10-02

Review 8.  Intestinal failure-associated liver disease: what do we know today?

Authors:  Deirdre A Kelly
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

9.  Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.

Authors:  Kathleen M Gura; Sang Lee; Clarissa Valim; Jing Zhou; Sendia Kim; Biren P Modi; Danielle A Arsenault; Robbert A M Strijbosch; Suzanne Lopes; Christopher Duggan; Mark Puder
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

10.  Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).

Authors:  George Ekema; Diego Falchetti; Giovanni Boroni; Anna Rita Tanca; Cristian Altana; Laura Righetti; Michela Ridella; Marco Gambarotti; Luisa Berchich
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545
  10 in total
  4 in total

1.  Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literature.

Authors:  Emma M Tillman; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

Review 2.  Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease.

Authors:  Shishira Bharadwaj; Tushar Gohel; Omer J Deen; Robert DeChicco; Abdullah Shatnawei
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-04-08

Review 3.  The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).

Authors:  Melissa I Chang; Mark Puder; Kathleen M Gura
Journal:  Nutrients       Date:  2012-11-27       Impact factor: 5.717

Review 4.  Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.

Authors:  Fedja A Rochling
Journal:  Nutrients       Date:  2021-03-10       Impact factor: 5.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.